Brain Cancer

Astrocytoma

Male, 35 years

Patient Internal 1292762649

ICD-10 code

C71.1 Malignant Neoplasm of Frontal Lobe

Diagnosis (Incl. Metastases/Stage) and Year

April 2021
Astrocytoma, WHO grade 4, IDH1/2 mutations. The tumor spread to the Left Frontotemporal Lobe.

Previous Treatment

Surgery, Radiation Therapy, Chemotherapy (Temozolomide).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~14 months from diagnosis.

Treatment Provided

Autologous DCV (4 doses) and CIK (4 doses) with Interleukin-2 over a period of 2 months.
Additionally, the patient received Nasal Drops of Exosomes with Paclitaxel.

Patient Survival/Condition and Year
Date of Review: 01/02/2024

The patient has survived for 34 months since the diagnosis. Since the beginning of the disease, the patient suffered neurological symptoms, however, the latest MRI scan shows no noticeable disease progression. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 20 months so far.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok